|Articles|January 19, 2023
Leveraging efficiency from cell line development to clinical manufacturing of monoclonal antibodies
Author(s)Curia
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
New Cellevate Nanofiber Microcarriers Aim to Transform Vaccine Manufacturing Processes
2
Analytics, Automation, and Quality Driving the Next Era of Drug Development
3
In KPMG's CEO Outlook, AI, Regulatory Demands, and Supply Chain Risk Rank High
4
Overcoming Funding Challenges and Maintaining Optimism in CGTs (Part 1)
5
